IDIOPATHIC INFLAMMATORY MYOPATHY (IIM)
Clinical trials for IDIOPATHIC INFLAMMATORY MYOPATHY (IIM) explained in plain language.
Never miss a new study
Get alerted when new IDIOPATHIC INFLAMMATORY MYOPATHY (IIM) trials appear
Sign up with your email to follow new studies for IDIOPATHIC INFLAMMATORY MYOPATHY (IIM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New antibody drug targets autoimmune diseases in early trial
Disease control Recruiting nowThis early-phase study tests a new drug called OM336 in 39 adults with active Sjogren's disease or idiopathic inflammatory myopathy who have not improved with at least two prior treatments. OM336 is an engineered antibody designed to target and potentially reduce harmful immune c…
Matched conditions: IDIOPATHIC INFLAMMATORY MYOPATHY (IIM)
Phase: PHASE1 • Sponsor: Ouro Medicines • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
CAR t therapy takes on lupus, MS, and more in first human safety trial
Disease control Recruiting nowThis early-stage study tests a new treatment called HBI0101 CAR T for people with severe autoimmune diseases like lupus, multiple sclerosis, and rheumatoid arthritis that haven't improved with standard treatments. The main goal is to find a safe dose and check for side effects in…
Matched conditions: IDIOPATHIC INFLAMMATORY MYOPATHY (IIM)
Phase: PHASE1 • Sponsor: Polina Stepensky • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
CAR-T cells take on stubborn muscle disease in first human test
Disease control Recruiting nowThis early-phase trial tests a new treatment called GC012F, which uses a patient's own immune cells (CAR-T cells) to target and attack the cause of idiopathic inflammatory myopathy, a group of rare muscle diseases. The study will enroll 12 adults whose disease has not responded t…
Matched conditions: IDIOPATHIC INFLAMMATORY MYOPATHY (IIM)
Phase: EARLY_PHASE1 • Sponsor: Daishi Tian • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Immune cell therapy shows promise for tough autoimmune cases
Disease control Recruiting nowThis study tests a new treatment using specially engineered immune cells (CAR-NK) from cord blood for people with severe autoimmune diseases like lupus, scleroderma, and vasculitis that haven't responded to standard therapies. The goal is to see if it's safe and can control the d…
Matched conditions: IDIOPATHIC INFLAMMATORY MYOPATHY (IIM)
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New 'Smart' immune therapy takes on lupus and arthritis
Disease control Recruiting nowThis early-phase study is testing a new drug called CC312 in 18 adults with severe autoimmune diseases like lupus and rheumatoid arthritis that haven't improved with standard treatments. CC312 is a type of immune therapy designed to target and destroy faulty B cells, similar to C…
Matched conditions: IDIOPATHIC INFLAMMATORY MYOPATHY (IIM)
Phase: EARLY_PHASE1 • Sponsor: CytoCares Inc • Aim: Disease control
Last updated Jun 26, 2026 18:43 UTC
-
New blood test could end Trial-and-Error for arthritis drugs
Diagnosis Recruiting nowThis study is testing a new blood-based test that aims to predict which medication will work best for each person with rheumatic diseases like rheumatoid arthritis or lupus. Researchers will take a blood sample and analyze immune cells to create a personalized treatment profile. …
Matched conditions: IDIOPATHIC INFLAMMATORY MYOPATHY (IIM)
Sponsor: University of Bonn • Aim: Diagnosis
Last updated Jun 26, 2026 13:02 UTC